Nebu-Flow secures £4.7 million investment to accelerate next-generation respiratory pharmaceuticals, poised to revolutionize drug delivery for respiratory disorders.

“At Nebu~Flow, we are proud to lead the charge in reshaping the future of inhalation drug delivery to treat respiratory disorders,” remarked chairman Dr John Pritchard.